Anti-CD34 monoclonal antibody coated coronary stent - OrbusNeich

Drug Profile

Anti-CD34 monoclonal antibody coated coronary stent - OrbusNeich

Alternative Names: Anti-CD34 antibody coated stent; Genous Bio-engineered R stent; Genous R Stent

Latest Information Update: 22 Apr 2013

Price : $50

At a glance

  • Originator OrbusNeich
  • Class Ischaemic heart disorder therapies; Macrolides; Monoclonal antibodies
  • Mechanism of Action Angiogenesis inducing agents
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Coronary artery restenosis; Coronary thrombosis

Most Recent Events

  • 01 Aug 2005 Launched for Coronary thrombosis (prevention) in World (Intracoronary)
  • 01 Aug 2005 Launched for Coronary artery restenosis (prevention) in World (Intracoronary)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top